These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13088923)

  • 1. Effect of phenylbutazone on uric acid excretion in patients with gout and rheumatoid arthritis.
    BISHOP C; BEECHER L
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):603-5. PubMed ID: 13088923
    [No Abstract]   [Full Text] [Related]  

  • 2. Isotopic uric acid in gouty and rheumatoid arthritis patients treated with probenecid and phenylbutazone.
    BISHOP C; BEYER A; TALBOTT JH
    Proc Soc Exp Biol Med; 1954; 86(4):760-2. PubMed ID: 13204347
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.
    KUZELL WC; SCHAFFARZICK RW; BROWN B; MANKLE EA
    J Am Med Assoc; 1952 Jun; 149(8):729-34. PubMed ID: 14927431
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical studies of phenylbutazone (butazolidin) and butapyrin (irgapyrin) in rheumatoid arthritis, rheumatoid spondylitis, and gout.
    KIDD EG; BOYCE KC; FREYBERG RH
    Ann Rheum Dis; 1953 Mar; 12(1):20-4. PubMed ID: 13031444
    [No Abstract]   [Full Text] [Related]  

  • 5. [Variations in uric acid in blood and urine during incorporation of phenylbutazone].
    SCHAPOSNIK F; DE FALCO JC; GUTIERREZ A
    Prensa Med Argent; 1956 Feb; 43(5):429-32. PubMed ID: 13335761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of rheumatic arthritis and gout with phenylbutazone].
    PLICHET A
    Presse Med (1893); 1952 Sep; 60(58):1217-8. PubMed ID: 13026950
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of sulfinpyrazone on uricemia and excretion of uric acid in 50 gouty hyperuricemic patients during diuretic thermal treatment. Comparison of its action in simple gout patients and in tophaceous gout patients].
    MUGLER A
    Presse Med (1893); 1961 May; 69():1072-4. PubMed ID: 13773609
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of phenylbutazone on uric acid metabolism.
    MASON RM
    Br Med J; 1954 Apr; 1(4865):788-92. PubMed ID: 13140862
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.
    KUZELL WC; SCHAFFARZICK RW
    Calif Med; 1952 Nov; 77(5):319-25. PubMed ID: 13009482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.
    GUTMAN AB; YU TF
    Trans Assoc Am Physicians; 1951; 64():279-88. PubMed ID: 14884260
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of phenylbutazone (butazolidin) in the treatment of gout, rheumatoid spondylitis, rheumatoid arthritis and other conditions of the musculoskeletal system.
    TOONE EC; IRBY R
    South Med J; 1957 May; 50(5):655-62. PubMed ID: 13433005
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical and metabolic effects of benemid in patients with gout.
    TALBOTT JH; BISHOP C; NORCROSS BM; LOCKIE LM
    Trans Assoc Am Physicians; 1951; 64():372-7. PubMed ID: 14884273
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenylbutazone in management of rheumatoid arthritis, rheumatoid spondylitis, and gouty arthritis.
    MACKNIGHT JC; IRBY R; TOONE EC
    Geriatrics; 1954 Mar; 9(3):111-5. PubMed ID: 13128310
    [No Abstract]   [Full Text] [Related]  

  • 14. [ACUTE RECURRENT OLIGOARTICULAR GOUT. (STIMULATION OF RHEUMATOID ARTHRITIS)].
    GRAVANO L
    Dia Med; 1964 Apr; 36():325-32. PubMed ID: 14152386
    [No Abstract]   [Full Text] [Related]  

  • 15. GOUT.
    REAH TG
    Practitioner; 1964 Sep; 193():306-14. PubMed ID: 14213731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uric acid excretion in hyperuricemia and gout].
    FRIEDRICH S; MUGLER A
    Strasb Med; 1956 Jul; 7(7):492-503. PubMed ID: 13360594
    [No Abstract]   [Full Text] [Related]  

  • 17. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
    BURNS JJ; YU TF; RITTERBAND A; PEREL JM; GUTMAN AB; BRODIE BB
    J Pharmacol Exp Ther; 1957 Mar; 119(3):418-26. PubMed ID: 13417097
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.
    HUFFMAN ER; WILSON GM; SMYTH CJ; HILL R
    Ann Rheum Dis; 1954 Dec; 13(4):317-23. PubMed ID: 13229240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of a uricosuric agent associated with the thermal diuresis treatment on uricemia and the excretion of uric acid in 50 hyperuricemic gout patients. Comparison of the action in patients with simple gout and trophic gout].
    MUGLER A
    Rein Foie; 1961 4th Trimest; 2():147-60. PubMed ID: 14476992
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ACTH and sodium salicylate on the urinary uric acid: creatinine ratio, and circulating eosinophils in man.
    MARSON FG
    Ann Rheum Dis; 1953 Dec; 12(4):296-300. PubMed ID: 13125229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.